VSTS

Vestis Corp. 10-Q Summary: Period Ended June 27, 2025

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 27, 2025 (Q2 Fiscal 2025) and the nine-month period ended June 27, 2025. Vestis Corporation is a leading provider of uniforms and workplace supplies in the United States and Canada, operating through two reportable segments: United States and Canada. The company serves diverse industries including manufacturing, healthcare, and hospitality through recurring rental and direct sales models.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Revenue decreased 3.5% ($24.4 million) in Q2 and 4.7% ($98.7 million) for the nine months compared to the prior year. This was driven by lost business exceeding new business and a significant loss of a national account customer impacting direct sales.
• Profitability Compression: Operating income dropped 33.5% in Q2 and 63.5% for the nine months. The nine-month decline was exacerbated by a $15.0 million adjustment to the allowance for credit losses (bad debt) and $11.4 million in severance charges related to executive departures.
• Net Loss: The company reported a net loss of $0.7 million in Q2 and $27.7 million for the nine months, compared to net income of $5.0 million and $23.3 million, respectively, in the prior year periods.
• Segment Performance: The U.S. segment saw operating income margins compress from 10.1% to 6.6% in Q2. The Canada segment revenue declined slightly, but operating income improved in Q2 due to cost management.

Guidance, Outlook, and Risks

• Credit Agreement Amendment: On May 1, 2025, Vestis amended its Credit Agreement, raising the net leverage covenant ratio to 5.25x through mid-2026. Crucially, the amendment restricted all dividends and share repurchases until the company achieves a net leverage ratio of 4.50x for two consecutive quarters or until after October 2026.
• Goodwill Impairment Test: Due to a decline in financial performance and share price, the company performed a quantitative goodwill impairment test as of June 27, 2025. No impairment was recognized, but management warned that future declines in market capitalization or operating results could trigger charges.
• Liquidity: The company maintains $23.7 million in cash and $266.3 million in revolver availability. It relies on an Accounts Receivable (A/R) Securitization Facility ($250 million limit) to manage liquidity.
• Legal Proceedings: The company is facing multiple shareholder class action lawsuits and derivative actions alleging breaches of fiduciary duty and misleading statements regarding pricing and financial results. A $3.1 million settlement regarding a pricing dispute with customers was finalized and paid in Q2.
• Macro Risks: Risks include inflationary pressures, supply chain disruptions, fuel costs, and potential tariff impacts from U.S.-Canada-Mexico trade discussions.

Investor Verification Checklist

• Credit Covenant Compliance: Verify the company's ability to meet the amended 5.25x net leverage ratio and the timeline for restoring dividend eligibility.
• Bad Debt Exposure: Assess the sustainability of the $15.0 million credit loss adjustment and the adequacy of the current $30.8 million allowance for credit losses.
• Customer Concentration: Evaluate the impact of the lost national account customer on future direct sales revenue and the pipeline for replacement business.
• Legal Liabilities: Monitor the status of the pending shareholder class actions and derivative suits, which could result in unspecified damages.
• Goodwill Valuation: Watch for future triggers that could necessitate goodwill impairment charges given the recent share price volatility.